Avacta Group Plc

53.80pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:AVCTHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (4.95%)
Div yield —
ROE (1965.14%)
Biotechnology
Beta (5Y) (0.15)
PE TTM —
TSR TTM (23.14%)
Mkt cap £261.9M
ROIC (84.95%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
66p
23.50%
(53.10%)
Buy 10|1|8|1|2
4Q25
1Q26
2Q26
3Q26
Earnings per share£
0.94
0.99
0.95
1.04
18.91%
23.65%
8.41%
6.27%
Revenue£M
20.33
19.91
20.35
21.33
9.63%
3.66%
8.99%
8.87%
Peers (US$352.4M)
Cap (US$)
PE
393.9M
203.0x
Capital
TTM
5Y
10Y
Leveragex
0.539
(0.106)
(0.098)
EBIT/Intx
0.642
0.357
0.293
Own earn%
29.52
(11.64)
(44.59)
Sh yield%
24.39
33.48
34.16
Owners
Insiders/Inst%
4.99
70.59
Short interest%
5.86
SBC / revenue%
3.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
19–29
$1 testx
—
Incr. ROIC%
21